Alnylam Pharmaceuticals reported $-191686000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Arrowhead Research ARWR:US $ -72909000 114.46M
Avrobio Inc AVRO:US -27774000 1.64M
Biocryst Pharmaceuticals BCRX:US $ -34.72M 15.24M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Novartis NVS:US $ 2228M 624M
Ptc Therapeutics PTCT:US $ -92.36M 5.84M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Takeda 4502:JP Y 150515M 152134M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
Xencor XNCR:US $ -28M 54.47M
YTE INCY:US $ 254.43M 137.89M